Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing

Anna Bartoletti-Stella, Simone Baiardi, Michelangelo Stanzani-Maserati, Silvia Piras, Paolo Caffarra, Alberto Raggi, Roberta Pantieri, Sara Baldassari, Leonardo Caporali, Samir Abu-Rumeileh, Simona Linarello, Rocco Liguori, Piero Parchi, Sabina Capellari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Genetics is intricately involved in the etiology of neurodegenerative dementias. The incidence of monogenic dementia among all neurodegenerative forms is unknown due to the lack of systematic studies and of patient/clinician access to extensive diagnostic procedures. In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions. Forty-nine patients (19.9%) carried known pathogenic or novel, likely pathogenic, variants, involving both common (presenilin 1, presenilin 2, C9orf72, and granulin) and rare (optineurin, serpin family I member 1 and protein kinase cyclic adenosine monophosphate (cAMP)-dependent type I regulatory subunit beta) dementia-associated genes. Our results support the use of an extended next-generation sequencing panels as a quick, accurate, and cost-effective method for diagnosis in clinical practice. This approach could have a significant impact on the proportion of tested patients, especially among those with an early disease onset.

Original languageEnglish
Pages (from-to)180.e23-180.e31
JournalNeurobiology of Aging
Volume66
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Dementia
Genes
Presenilin-2
Presenilin-1
Serpins
Cyclic AMP-Dependent Protein Kinases
Costs and Cost Analysis
Mutation
Incidence

Keywords

  • C9orf72 RE
  • Double mutations
  • Familial dementia
  • Neurodegenerative dementia
  • Next-generation sequencing
  • Targeted gene sequencing

ASJC Scopus subject areas

  • Neuroscience(all)
  • Ageing
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing. / Bartoletti-Stella, Anna; Baiardi, Simone; Stanzani-Maserati, Michelangelo; Piras, Silvia; Caffarra, Paolo; Raggi, Alberto; Pantieri, Roberta; Baldassari, Sara; Caporali, Leonardo; Abu-Rumeileh, Samir; Linarello, Simona; Liguori, Rocco; Parchi, Piero; Capellari, Sabina.

In: Neurobiology of Aging, Vol. 66, 01.06.2018, p. 180.e23-180.e31.

Research output: Contribution to journalArticle

Bartoletti-Stella, Anna ; Baiardi, Simone ; Stanzani-Maserati, Michelangelo ; Piras, Silvia ; Caffarra, Paolo ; Raggi, Alberto ; Pantieri, Roberta ; Baldassari, Sara ; Caporali, Leonardo ; Abu-Rumeileh, Samir ; Linarello, Simona ; Liguori, Rocco ; Parchi, Piero ; Capellari, Sabina. / Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing. In: Neurobiology of Aging. 2018 ; Vol. 66. pp. 180.e23-180.e31.
@article{05def497df7143fcb2d05bd73c858816,
title = "Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing",
abstract = "Genetics is intricately involved in the etiology of neurodegenerative dementias. The incidence of monogenic dementia among all neurodegenerative forms is unknown due to the lack of systematic studies and of patient/clinician access to extensive diagnostic procedures. In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions. Forty-nine patients (19.9{\%}) carried known pathogenic or novel, likely pathogenic, variants, involving both common (presenilin 1, presenilin 2, C9orf72, and granulin) and rare (optineurin, serpin family I member 1 and protein kinase cyclic adenosine monophosphate (cAMP)-dependent type I regulatory subunit beta) dementia-associated genes. Our results support the use of an extended next-generation sequencing panels as a quick, accurate, and cost-effective method for diagnosis in clinical practice. This approach could have a significant impact on the proportion of tested patients, especially among those with an early disease onset.",
keywords = "C9orf72 RE, Double mutations, Familial dementia, Neurodegenerative dementia, Next-generation sequencing, Targeted gene sequencing",
author = "Anna Bartoletti-Stella and Simone Baiardi and Michelangelo Stanzani-Maserati and Silvia Piras and Paolo Caffarra and Alberto Raggi and Roberta Pantieri and Sara Baldassari and Leonardo Caporali and Samir Abu-Rumeileh and Simona Linarello and Rocco Liguori and Piero Parchi and Sabina Capellari",
note = "{"}Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Liguori Rocco, Parchi Piero, Capellari Sabina)",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.neurobiolaging.2018.02.006",
language = "English",
volume = "66",
pages = "180.e23--180.e31",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing

AU - Bartoletti-Stella, Anna

AU - Baiardi, Simone

AU - Stanzani-Maserati, Michelangelo

AU - Piras, Silvia

AU - Caffarra, Paolo

AU - Raggi, Alberto

AU - Pantieri, Roberta

AU - Baldassari, Sara

AU - Caporali, Leonardo

AU - Abu-Rumeileh, Samir

AU - Linarello, Simona

AU - Liguori, Rocco

AU - Parchi, Piero

AU - Capellari, Sabina

N1 - "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Liguori Rocco, Parchi Piero, Capellari Sabina)

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Genetics is intricately involved in the etiology of neurodegenerative dementias. The incidence of monogenic dementia among all neurodegenerative forms is unknown due to the lack of systematic studies and of patient/clinician access to extensive diagnostic procedures. In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions. Forty-nine patients (19.9%) carried known pathogenic or novel, likely pathogenic, variants, involving both common (presenilin 1, presenilin 2, C9orf72, and granulin) and rare (optineurin, serpin family I member 1 and protein kinase cyclic adenosine monophosphate (cAMP)-dependent type I regulatory subunit beta) dementia-associated genes. Our results support the use of an extended next-generation sequencing panels as a quick, accurate, and cost-effective method for diagnosis in clinical practice. This approach could have a significant impact on the proportion of tested patients, especially among those with an early disease onset.

AB - Genetics is intricately involved in the etiology of neurodegenerative dementias. The incidence of monogenic dementia among all neurodegenerative forms is unknown due to the lack of systematic studies and of patient/clinician access to extensive diagnostic procedures. In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions. Forty-nine patients (19.9%) carried known pathogenic or novel, likely pathogenic, variants, involving both common (presenilin 1, presenilin 2, C9orf72, and granulin) and rare (optineurin, serpin family I member 1 and protein kinase cyclic adenosine monophosphate (cAMP)-dependent type I regulatory subunit beta) dementia-associated genes. Our results support the use of an extended next-generation sequencing panels as a quick, accurate, and cost-effective method for diagnosis in clinical practice. This approach could have a significant impact on the proportion of tested patients, especially among those with an early disease onset.

KW - C9orf72 RE

KW - Double mutations

KW - Familial dementia

KW - Neurodegenerative dementia

KW - Next-generation sequencing

KW - Targeted gene sequencing

UR - http://www.scopus.com/inward/record.url?scp=85042934377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042934377&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2018.02.006

DO - 10.1016/j.neurobiolaging.2018.02.006

M3 - Article

C2 - 29525180

AN - SCOPUS:85042934377

VL - 66

SP - 180.e23-180.e31

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -